Health Canada inspection
Dainippon Sumitomo Pharma Co., Ltd.: Health Canada inspection of Feb 17, 2017
Health Canada · GMP · rating C
Key facts
| Establishment | Dainippon Sumitomo Pharma Co., Ltd. |
|---|---|
| City | Oita |
| Province | Ôita |
| Country | Japan |
| Program | GMP |
| Start date | Feb 9, 2017 |
| End date | Feb 17, 2017 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.